William Mann, Ph.D., has been appointed chief executive officer for Helsinn Group’s American subsidiary, Helsinn Therapeutics (U.S.) Inc. Dr. Mann previously served as chief operating officer of the recently acquired Helsinn Therapeutics. He has also held leadership positions with a Swiss multinational in business development and research. Also, William Brown has been named vice president commercial operations to build a direct sales structure for Helsinn Therapeutics in the U.S. Mr. Brown ha...